Low profile delivery system for transcatheter heart valve

    公开(公告)号:US10441419B2

    公开(公告)日:2019-10-15

    申请号:US16197245

    申请日:2018-11-20

    Abstract: A method of delivery a prosthetic heart valve includes inserting a delivery apparatus and a prosthetic heart valve into a patient's vasculature. The delivery apparatus includes a steerable guide catheter, a balloon catheter, and a flex indicator. The balloon catheter extends coaxially through the guide catheter, the prosthetic heart valve is mounted on a distal end portion of the balloon catheter, and the flex indicator is movably coupled to a handle of the guide catheter. The method further includes adjusting flexion of a steerable section of the guide catheter to position the prosthetic heart valve. The flex indicator moves relative to the handle of the guide catheter as the flexion of the steerable section is adjusted, and the handle comprises one or more visual indicators adjacent the flex indicator to provide visual indication of an amount of flexion of the steerable section of the guide catheter.

    Cardiac valve repair devices configured for percutaneous delivery

    公开(公告)号:US10278819B2

    公开(公告)日:2019-05-07

    申请号:US15167760

    申请日:2016-05-27

    Abstract: Disclosed herein are devices for improving coaption of the mitral valve leaflets to reduce or eliminate mitral valve regurgitation. The devices may be used to perform mitral valve annuloplasty, or to serve as a docking station for a transcatheter prosthetic heart valve. The various embodiments of devices are configured for percutaneous and, in some cases, transvascular delivery. Delivery systems useful for routing the devices to the mitral valve are also disclosed, including catheters, balloons and/or mechanical expansion systems. The devices themselves include at least one tissue penetrating member. Methods of delivery include partially embedding the devices in the mitral valve annulus via at least one tissue penetrating member. Tissue penetrating members may be embedded into the tissue in a simultaneous or a nearly simultaneous fashion. Upon embedding, the devices employ various expansion and/or contraction features to adjust the mitral valve diameter. Adjustments may continue until the leaflets fully coapt and the problem of mitral regurgitation is reduced or eliminated.

    SUTURE LOCK ASSEMBLY WITH A SUTURE TENSIONER

    公开(公告)号:US20250114088A1

    公开(公告)日:2025-04-10

    申请号:US18984170

    申请日:2024-12-17

    Abstract: Suture lock assemblies with suture tensioners are disclosed herein. A suture lock assembly can comprise a suture tensioner configured to be selectively rotated to collect a length of a suture. The suture tensioner comprises a pair of spaced-apart posts and a connecting body coupled to each of the posts. A suture lock assembly also can comprise a suture tensioner, a tensioner housing, and a quick release suture mechanism. The tensioner housing at least partially receives the suture tensioner and includes a suture entry port and a suture exit port. The suture tensioner is configured to be selectively rotated relative to the tensioner housing to selectively increase a length of a suture that is enclosed by the tensioner housing. The quick release suture mechanism comprises a quick release dock port and a suture anchor cap configured to be selectively coupled to and uncoupled from the quick release dock port.

    Cardiac valve repair devices configured for percutaneous delivery

    公开(公告)号:US11166817B2

    公开(公告)日:2021-11-09

    申请号:US16358480

    申请日:2019-03-19

    Abstract: Disclosed herein are devices for improving coaption of the mitral valve leaflets to reduce or eliminate mitral valve regurgitation. The devices may be used to perform mitral valve annuloplasty, or to serve as a docking station for a transcatheter prosthetic heart valve. The various embodiments of devices are configured for percutaneous and, in some cases, transvascular delivery. Delivery systems useful for routing the devices to the mitral valve are also disclosed, including catheters, balloons and/or mechanical expansion systems. The devices themselves include at least one tissue penetrating member. Methods of delivery include partially embedding the devices in the mitral valve annulus via at least one tissue penetrating member. Tissue penetrating members may be embedded into the tissue in a simultaneous or a nearly simultaneous fashion. Upon embedding, the devices employ various expansion and/or contraction features to adjust the mitral valve diameter. Adjustments may continue until the leaflets fully coapt and the problem of mitral regurgitation is reduced or eliminated.

Patent Agency Ranking